Endometrial cancer - PubMed (original) (raw)
Review
Endometrial cancer
Joel I Sorosky. Obstet Gynecol. 2012 Aug.
Abstract
The epidemiology, prevention, diagnosis, treatment, prognosis, and new International Federation of Gynecology and Obstetrics staging system of endometrial carcinoma are reviewed. Endometrial cancer has increased 21% in incidence since 2008, and the death rate has increased more than 100% over the past two decades. Precursor lesions of complex hyperplasia with atypia are associated with an endometrial carcinoma in more than 40% of cases. Endometrial cancer in white women occurs at twice the incidence as in black women, but, stage for stage, black women have a less favorable prognosis. Preoperative imaging cannot accurately assess lymph node involvement. Gross examination of depth of myometrial invasion does not have the sensitivity, specificity, positive predictive value, or negative predictive value to select women who can have lymphadenectomy safely omitted from the surgical procedure. Although surgical staging remains the most accurate method of determining the extent of disease, the therapeutic value of pelvic lymphadenectomy has not been established. The anatomical extent of lymphadenectomy and the number of lymph nodes removed to establish prognostic and therapeutic benefit are controversial. Research efforts are directed at identifying women with early stage endometrial cancer who only require total hysterectomy and bilateral salpingo-oophorectomy. Minimally invasive surgical techniques have become established as standard therapy for treating women with endometrial cancer. Women with a family history of hereditary nonpolyposis colorectal cancer are at increased risk for endometrial cancer. Conservative treatment to allow for childbearing is possible in select situations. Women with endometrial cancer should be managed by physicians experienced in the complex multimodality treatment of this disease.
Similar articles
- Endometrial cancer.
Sorosky JI. Sorosky JI. Obstet Gynecol. 2008 Feb;111(2 Pt 1):436-47. doi: 10.1097/AOG.0b013e318162f690. Obstet Gynecol. 2008. PMID: 18238985 Review. - Use of the sentinel node procedure to stage endometrial cancer.
Ballester M, Dubernard G, Rouzier R, Barranger E, Darai E. Ballester M, et al. Ann Surg Oncol. 2008 May;15(5):1523-9. doi: 10.1245/s10434-008-9841-1. Epub 2008 Mar 6. Ann Surg Oncol. 2008. PMID: 18322758 - Influence of body mass index on clinicopathologic features, surgical morbidity and outcome in patients with endometrial cancer.
Akbayır O, Corbacıoglu Esmer A, Numanoglu C, Cılesız Goksedef BP, Akca A, Bakır LV, Kuru O. Akbayır O, et al. Arch Gynecol Obstet. 2012 Nov;286(5):1269-76. doi: 10.1007/s00404-012-2431-2. Epub 2012 Jun 24. Arch Gynecol Obstet. 2012. PMID: 22729137 - Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G, Angioli R, Tateo S, Mangili G, Katsaros D, Garozzo G, Campagnutta E, Donadello N, Greggi S, Melpignano M, Raspagliesi F, Ragni N, Cormio G, Grassi R, Franchi M, Giannarelli D, Fossati R, Torri V, Amoroso M, Crocè C, Mangioni C. Benedetti Panici P, et al. J Natl Cancer Inst. 2008 Dec 3;100(23):1707-16. doi: 10.1093/jnci/djn397. Epub 2008 Nov 25. J Natl Cancer Inst. 2008. PMID: 19033573 Clinical Trial. - Stage IB endometrial cancer. Does lymphadenectomy replace adjuvant radiotherapy?
Bottke D, Wiegel T, Kreienberg R, Kurzeder C, Sauer G. Bottke D, et al. Strahlenther Onkol. 2007 Nov;183(11):600-4. doi: 10.1007/s00066-007-1801-3. Strahlenther Onkol. 2007. PMID: 17960334 Review.
Cited by
- Tibial bone metastasis as an initial presentation of endometrial carcinoma diagnosed by fine-needle aspiration cytology: A case report and review of the literature.
Boukhar SA, Kaneshiro R, Schiller A, Terada K, Tauchi-Nishi P. Boukhar SA, et al. Cytojournal. 2015 May 21;12:11. doi: 10.4103/1742-6413.157507. eCollection 2015. Cytojournal. 2015. PMID: 26085835 Free PMC article. - Effect of metformin on proliferative markers in women with endometrial carcinoma: Systematic review and meta-analysis.
Shareef MA, Sofy AA, Abdelsattar AT, Masoud AT, Farhat AM, Maarouf H. Shareef MA, et al. Turk J Obstet Gynecol. 2022 Mar 28;19(1):35-44. doi: 10.4274/tjod.galenos.2022.26257. Turk J Obstet Gynecol. 2022. PMID: 35343218 Free PMC article. - Spatiotemporal trends in burden of uterine cancer and its attribution to body mass index in 204 countries and territories from 1990 to 2019.
Li S, Chen H, Zhang T, Li R, Yin X, Man J, He Q, Yang X, Lu M. Li S, et al. Cancer Med. 2022 Jun;11(12):2467-2481. doi: 10.1002/cam4.4608. Epub 2022 Feb 13. Cancer Med. 2022. PMID: 35156336 Free PMC article. - Integrative models of histopathological images and multi-omics data predict prognosis in endometrial carcinoma.
Li Y, Du P, Zeng H, Wei Y, Fu H, Zhong X, Ma X. Li Y, et al. PeerJ. 2023 Aug 11;11:e15674. doi: 10.7717/peerj.15674. eCollection 2023. PeerJ. 2023. PMID: 37583914 Free PMC article. - Bioinformatics Analysis of Immune Infiltration In Endometrial Carcinoma Tumors and its Relationship With Prognosis.
Lin Y, Liu S, Bian L, Lin C, Lin P, Teng Z, Hoffman RM, Zhu G, Zhang B. Lin Y, et al. Cancer Diagn Progn. 2023 Jul 3;3(4):416-427. doi: 10.21873/cdp.10234. eCollection 2023 Jul-Aug. Cancer Diagn Progn. 2023. PMID: 37405226 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous